SCHEMBL14019448

SCHEMBL14019448

CCOC(=O)c1oc(Cc2ccccc2C)nc1C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC26A6 Q9BXS9 2/20 0.44
PSEN1 P49768 1/20 0.42
PSEN2 P49810 1/20 0.42
APH1B Q8WW43 1/20 0.42
NCSTN Q92542 1/20 0.42
APH1A Q96BI3 1/20 0.42
PSENEN Q9NZ42 1/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
KDM4E B2RXH2 3/20 0.42
AHR P35869 1/20 0.42
CYP1A2 P05177 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
NPC1 O15118 2/20 0.41
MAPT P10636 2/20 0.41
RAB9A P51151 2/20 0.41
ALDH1A1 P00352 2/20 0.41
LMNA P02545 1/20 0.41
GAA P10253 1/20 0.41
HPGD P15428 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3822762 0.84 SMN1; SMN2 (0.49) KMT2AKDM4EAHRCYP1A2SMN1; SMN2
SCHEMBL14019446 0.78 TARBP2 (0.46) MEN1KMT2AKDM4ECYP1A2SMN1; SMN2
SCHEMBL3823043 0.77 MAPT (0.48) KDM4EAHRCYP1A2SMN1; SMN2NPC1
SCHEMBL4887366 0.77 SLC26A6 (0.46) SLC26A6KMT2ACYP1A2SMN1; SMN2NPC1
SCHEMBL892287 0.76 SLC26A6 (0.52) SLC26A6MEN1KMT2AKDM4ECYP1A2
SCHEMBL14019449 0.76 HDAC4 (0.42) KDM4EAHRCYP1A2SMN1; SMN2NPC1
SCHEMBL3822181 0.74 FBP1 (0.41) MEN1KMT2AKDM4EAHRCYP1A2
SCHEMBL11622665 0.72 TARBP2 (0.63) KMT2AKDM4ESMN1; SMN2NPC1MAPT
SCHEMBL3821702 0.72 SMN1; SMN2 (0.48) KMT2AKDM4ESMN1; SMN2NPC1MAPT
SCHEMBL13678351 0.72 FBP1 (0.37) KDM4EAHRCYP1A2SMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080255202-A1 Phenylthioacetic Acid Derivatives and Use Thereof BAYER HEALTHCARE AG (DE) 2008-10-16 US disclosed
US-20080255202-A1 Phenylthioacetic Acid Derivatives and Use Thereof BAYER HEALTHCARE AG (DE) 2008-10-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080255202-A1 Phenylthioacetic Acid Derivatives and Use Thereof PAH, TST, MPST SLC26A6 110/4885PSEN1 1046/4885PSEN2 1174/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.